Beam TherapeuticsInc Stock Probability of Future Stock Price Finishing Over 46.82

BEAM
 Stock
  

USD 46.82  0.99  2.16%   

Beam TherapeuticsInc's future price is the expected price of Beam TherapeuticsInc instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Beam TherapeuticsInc performance during a given time horizon utilizing its historical volatility. Beam TherapeuticsInc Price to Book Value is relatively stable at the moment as compared to the past year. The company's current Price to Book Value is estimated at 8.90. Price to Sales Ratio is expected to hike to 101.32 this year, although the value of Price to Earnings Ratio will most likely fall to (14.90) .
  
Continue to Beam TherapeuticsInc Backtesting, Beam TherapeuticsInc Valuation, Beam TherapeuticsInc Correlation, Beam TherapeuticsInc Hype Analysis, Beam TherapeuticsInc Volatility, Beam TherapeuticsInc History as well as Beam TherapeuticsInc Performance. Please specify Beam TherapeuticsInc time horizon, a valid symbol (red box) and a target price (blue box) you would like Beam TherapeuticsInc odds to be computed.

Beam TherapeuticsInc Target Price Odds to finish over 46.82

The tendency of Beam TherapeuticsInc Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 46.82 90 days 46.82 
about 62.37
Based on a normal probability distribution, the odds of Beam TherapeuticsInc to move above the current price in 90 days from now is about 62.37 (This Beam TherapeuticsInc probability density function shows the probability of Beam TherapeuticsInc Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.04 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Beam TherapeuticsInc will likely underperform. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Beam TherapeuticsInc is significantly underperforming NYSE Composite.
   Beam TherapeuticsInc Price Density   
       Price  

Predictive Modules for Beam TherapeuticsInc

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Beam TherapeuticsInc. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Beam TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Beam TherapeuticsInc in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
40.4745.5250.57
Details
Intrinsic
Valuation
LowReal ValueHigh
41.2564.0069.05
Details
11 Analysts
Consensus
LowTarget PriceHigh
85.00124.50159.00
Details
Earnings
Estimates (5)
LowProjected EPSHigh
-5.9-5.66-5.42
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Beam TherapeuticsInc. Your research has to be compared to or analyzed against Beam TherapeuticsInc's peers to derive any actionable benefits. When done correctly, Beam TherapeuticsInc's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Beam TherapeuticsInc.

Beam TherapeuticsInc Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Beam TherapeuticsInc is not an exception. The market had few large corrections towards the Beam TherapeuticsInc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Beam TherapeuticsInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Beam TherapeuticsInc within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.32
β
Beta against NYSE Composite2.04
σ
Overall volatility
4.79
Ir
Information ratio -0.04

Beam TherapeuticsInc Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Beam TherapeuticsInc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Beam TherapeuticsInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Beam TherapeuticsInc generated a negative expected return over the last 90 days
Beam TherapeuticsInc has high historical volatility and very poor performance
The company reported the previous year's revenue of 51.84 M. Net Loss for the year was (370.64 M) with loss before overhead, payroll, taxes, and interest of (180.29 M).
Beam TherapeuticsInc currently holds about 1.09 B in cash with (66.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.9.
Beam TherapeuticsInc has a poor financial position based on the latest SEC disclosures
Over 87.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease - Yahoo Finance

Beam TherapeuticsInc Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Beam TherapeuticsInc Stock often depends not only on the future outlook of the current and potential Beam TherapeuticsInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Beam TherapeuticsInc's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding46733221.00
Cash And Short Term Investments965647000.00

Beam TherapeuticsInc Technical Analysis

Beam TherapeuticsInc's future price can be derived by breaking down and analyzing its technical indicators over time. Beam TherapeuticsInc Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Beam TherapeuticsInc. In general, you should focus on analyzing Beam TherapeuticsInc Stock price patterns and their correlations with different microeconomic environments and drivers.

Beam TherapeuticsInc Predictive Forecast Models

Beam TherapeuticsInc time-series forecasting models is one of many Beam TherapeuticsInc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Beam TherapeuticsInc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Beam TherapeuticsInc

Checking the ongoing alerts about Beam TherapeuticsInc for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Beam TherapeuticsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Beam TherapeuticsInc generated a negative expected return over the last 90 days
Beam TherapeuticsInc has high historical volatility and very poor performance
The company reported the previous year's revenue of 51.84 M. Net Loss for the year was (370.64 M) with loss before overhead, payroll, taxes, and interest of (180.29 M).
Beam TherapeuticsInc currently holds about 1.09 B in cash with (66.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.9.
Beam TherapeuticsInc has a poor financial position based on the latest SEC disclosures
Over 87.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease - Yahoo Finance
Continue to Beam TherapeuticsInc Backtesting, Beam TherapeuticsInc Valuation, Beam TherapeuticsInc Correlation, Beam TherapeuticsInc Hype Analysis, Beam TherapeuticsInc Volatility, Beam TherapeuticsInc History as well as Beam TherapeuticsInc Performance. Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Beam TherapeuticsInc Stock analysis

When running Beam TherapeuticsInc price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam TherapeuticsInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.3 B
Quarterly Revenue Growth YOY
19.71
Return On Assets
(0.08) 
Return On Equity
(0.40) 
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam TherapeuticsInc that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Beam TherapeuticsInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.